COVID-19 : Cynbiose and VirPath team up in a collaborative R&D project related to the SARS-CoV-2outbreak

10 June 2020


Cynbiose in  partnership with the academic laboratory VirPath announced today the launch of the COVIBIOSE project.

The COVIBIOSE project aims to develop and  characterize an innovative non-human primate (NHP) preclinical model to study the pathophysiology of the infection by SARS-CoV-2  and evaluate the efficacy of therapeutic or prophylactic candidates in order to fast-track them to clinic trials.  

This initiative is coordinated by the French cluster Lyonbiopôle and supported by the Auvergne-Rhône-Alpes region.

More information available in the press release.